Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine

<p>The emergence of novel coronavirus-2019 (COVID-19) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and its rapid spread across the world have triggered a global health emergency without preceding. From the first report of COVID-19 at Wuhan city of China in December 201...

Full description

Saved in:
Bibliographic Details
Main Author: Reynaldo Oliva-Hernández (Author)
Format: Book
Published: Journal of Vaccines and Immunology - Peertechz Publications, 2021-01-25.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_jvi_000037
042 |a dc 
100 1 0 |a Reynaldo Oliva-Hernández  |e author 
245 0 0 |a Considerations to accelerating and maximize the preclinical studies to a safe and effective COVID-19 vaccine 
260 |b Journal of Vaccines and Immunology - Peertechz Publications,   |c 2021-01-25. 
520 |a <p>The emergence of novel coronavirus-2019 (COVID-19) by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus and its rapid spread across the world have triggered a global health emergency without preceding. From the first report of COVID-19 at Wuhan city of China in December 2019 until today there has been an outbreak of COVID-19 around the world, with 97, 831, 595 confirmed cases and 2, 120, 877 death cases [1,2] and this number keeps growing.</p><p><br></p> 
540 |a Copyright © Reynaldo Oliva-Hernández et al. 
546 |a en 
655 7 |a Opinion  |2 local 
856 4 1 |u https://doi.org/10.17352/jvi.000037  |z Connect to this object online.